Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine

References

• Myers JS. Chemotherapy-related cognitive impairment: neuroimaging, neuropsychological testing, and the neuropsychologist. Clin J Oncol Nurs 2009;13:413–21.
   PubMed Web of Science ®Google Scholar
• van Dam FS, Schagen SB, Muller MJ, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998;90:210–218.
   PubMed Web of Science ®Google Scholar
• Scherling CS, Smith A. Opening up the window into “chemobrain”: a neuroimaging review. Sensors (Basel) 2013;13:3169–3203.
   PubMed Web of Science ®Google Scholar
• Hodgson KD, Hutchinson AD, Wilson CJ, et al. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev 2013;39:297–304.
   PubMed Web of Science ®Google Scholar
• Hutchinson AD, Hosking JR, Kichenadasse G, et al. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev 2012;38:926–934.
   PubMed Web of Science ®Google Scholar
• Rodin G, Ahles TA. Accumulating evidence for the effect of chemotherapy on cognition. J Clin Oncol 2012;30:3568–3569.
   PubMed Web of Science ®Google Scholar
• Schagen SB, Hamburger HL, Muller MJ, et al. Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neurooncol 2001;51:159–165.
   PubMed Web of Science ®Google Scholar
• Kreukels BP, Schagen SB, Ridderinkhof KR, et al. Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. Breast Cancer Res Treat 2005;94:53–61.
   PubMed Web of Science ®Google Scholar
• Angelakis E, Lubar JF, Stathopoulou S. Electroencephalographic peak alpha frequency correlates of cognitive traits. Neurosci Lett 2004;16;371:60–63.
   Web of Science ®Google Scholar
• Richard Clark C, Veltmeyer MD, Hamilton RJ, et al. Spontaneous alpha peak frequency predicts working memory performance across the age span. Int J Psychophysiol 2004;53:1–9.
   PubMed Web of Science ®Google Scholar
• Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Brain Res Rev 1999;29:169–195.
   PubMed Web of Science ®Google Scholar
• Seruga B, Zhang H, Bernstein LJ, et al. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 2008;8:887–899.
   PubMed Web of Science ®Google Scholar
• Ganz PA, Bower JE. Cancer related fatigue: a focus on breast cancer and Hodgkin's disease survivors. Acta Oncol 2007;46: 474–479.
   PubMed Web of Science ®Google Scholar
• Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001;24:677–736.
   PubMed Web of Science ®Google Scholar
• Norman DA, Shallice T. Attention to action: willed and automatic control of behaviour. In: Shapiro DL, Schwartz G, editors. Consciousness and self-regulation: advances in research. New York: Plenum Press; 1986. pp 1–14.
   Google Scholar
• Neuwirth W, Benesch M. Manual determination test. 35 ed. Mödling, Austria: Schuhfried GmbH; 2012.
   Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–376.
   PubMed Web of Science ®Google Scholar
• Doppelmayr M, Kliemesch W, Pachinger T, et al. Individual differences in brain dynamics: Important implications for the calculation of event related band power. Biol Cybern 1998;79:49–57.
   PubMed Web of Science ®Google Scholar
• Jensen RE, Arora NK, Bellizzi KM, et al. Health-related quality of life among survivors of aggressive non-Hodgkin lymphoma. Cancer 2013;119:672–680.
   PubMed Web of Science ®Google Scholar
• Küllmer A, Herrmann G, Riecken B. [Rapid-progressive decrease of cognitive and physical functions in a B-cell non-Hodgkin's lymphoma patient treated with rituximab/bendamustine]. Dtsch Med Wochenschr 2013;138:1355–1359.
   PubMed Web of Science ®Google Scholar
• Tholstrup D, Brown Pde N, Jurlander J, et al. Quality of life in patients with diffuse large B-cell lymphoma treated with dose-dense chemotherapy is only affected temporarily. Leuk Lymphoma 2011;52:400–408.
   PubMed Web of Science ®Google Scholar
• Arns M, Drinkenburg WH, Fitzgerald PB, et al. Neurophysiological predictors of non-response to rTMS in depression. Brain Stimul 2012;5:569–576.
   PubMed Web of Science ®Google Scholar
• Oral E, Canpolat S, Yildirim S, et al. Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder. Brain Res Bull 2012;88:454–459.
   PubMed Web of Science ®Google Scholar
• Bower JE, Ganz PA, Irwin MR, et al. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol 2011;29:3517–3522.
   PubMed Web of Science ®Google Scholar
• Elderkin-Thompson V, Mintz J, Haroon E, et al. Executive dysfunction and memory in older patients with major and minor depression. Arch Clin Neuropsychol 2007;22:261–270.
   PubMed Web of Science ®Google Scholar
• Patki G, Solanki N, Atrooz F, et al. Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress. Brain Res 2013;1529:73–86.
   Web of Science ®Google Scholar
• Wefel JS, Lenzi R, Theriault RL, et al. The cognitive sequelae of standard-dose adjuvant chemotherapy in woman with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 2004;100:2292–2299.
   PubMed Web of Science ®Google Scholar
• Jansen CE, Cooper BA, Dodd MJ, et al. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 2011;10:1647–1656.
   Web of Science ®Google Scholar